BioRestorative Therapies Enters New Employment Agreement with VP of R&D Francisco Silva

On June 10, 2026, BioRestorative Therapies, Inc. entered into a new employment agreement with Francisco Silva, the company's Vice President of Research and Development and Secretary. The agreement establishes a three-year term ending June 10, 2029, with automatic one-year extensions unless notice is provided. Mr. Silva's annual base salary remains at $575,000, and he is eligible for a discretionary annual cash bonus of up to 50% of his salary. The contract includes standard provisions for severance, including a Cash Severance Amount equal to 1.5 times the sum of his salary and maximum bonus if terminated without cause or if he resigns for good reason. Additionally, the agreement outlines restrictive covenants, including a one-year non-compete and non-solicitation period following termination. The filing also details Change in Control provisions that trigger severance payments and the immediate vesting of all outstanding equity awards. Mr. Silva will continue to report directly to the Chief Executive Officer while leading the development of the company's scientific programs and intellectual property.